References
- Meckstroth K R, Darney P D. Implant contraception. Sem Reprod Med 2001; 19: 339–54
- Glasier A. Implantable contraceptives for women: Effectiveness, discontinuation rates, return of fertility, and outcome of pregnancies. Contraception 2002; 65: 29–37
- Implanon® (etonogestrel implant). Full Prescribing Information. NV Organon, (part of Schering-Plough), OssThe Netherlands 2005
- Erkkola R, Landgren B M. Role of progestins in contraception. Acta Obstet Gynecol Scand 2005; 84: 207–16
- Coukell A J, Balfour J A. Levonorgestrel subdermal implants. A review of contraceptive efficacy and acceptability. Drugs 1998; 55: 861–87
- Post-marketing surveillance of Norplant® contraceptive implants: I. Contraceptive efficacy and reproductive health. Contraception 2001; 63: 167–86
- Sivin I, Campodonico I, Kiriwat O, et al. The performance of levonorgestrel rod and Norplant contraceptive implants: A 5 year randomized study. Hum Reprod 1998; 13: 3371–8
- Suhonen S, Haukkamaa M, Jakobsson T, et al. Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: A comparative study. Contraception 2004; 69: 407–12
- Cox M, Tripp J, Blacksell S. Clinical performance of the levonorgestrel intrauterine system in routine use by the UK Family Planning and Reproductive Health Research Network: 5-year report. J Fam Plann Reprod Health Care 2002; 28: 73–77
- Andersson K, Odlind V, Rybo G. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: A randomized comparative trial. Contraception 1994; 49: 56–72
- Klavon S L, Grubb G S. Insertion site complications during the first year of NORPLANT use. Contraception 1990; 41: 27–37
- Dunson T R, Amatya R N, Krueger S L. Complications and risk factors associated with the removal of Norplant implants. Obstet Gynecol 1995; 85: 543–8
- Brache V, Faundes A, Alvarez F. Risk-benefit effects of implantable contraceptives in women. Expert Opin Drug Saf 2003; 2: 321–32
- Biswas A, Viegas O A, Roy A C. Effect of Implanon and Norplant subdermal contraceptive implants on serum lipids – A randomized comparative study. Contraception 2003; 68: 189–93
- Mascarenhas L, van Beek A, Bennink H C, et al. Twenty-four month comparison of apolipoproteins A-1, A-II and B in contraceptive implant users (Norplant and Implanon) in Birmingham, United Kingdom. [erratum appears in Contraception 1998 Dec;58(6):following 389]. Contraception 1998; 58: 215–9
- Biswas A, Viegas O A, Coeling Bennink H J, et al. Implanon contraceptive implants: effects on carbohydrate metabolism. Contraception 2001; 63: 137–41
- Egberg N, Van Beek A, Gunnervik C, et al. Effects on the hemostatic system and liver function in relation to implanon and norplant: A prospective randomized clinical trial. Contraception 1998; 58: 93–98
- Beerthuizen R, van Beek A, Massai R, et al. Bone mineral density during long-term use of the progestagen contraceptive implant Implanon compared to a non-hormonal method of contraception. Hum Reprod 2000; 15: 118–22
- Dorflinger L J. Metabolic effects of implantable steroid contraceptives for women. Contraception 2002; 65: 47–62
- Dash D S, Das S, Nanda U, et al. Serum lipid profile in women using levonorgestrel contraceptive implant, Norplant-2. Contraception 1988; 37: 371–82
- Rabe T, Thuro H C, Goebel K, et al. Lipid metabolism in Norplant-2 users – A two-year follow-up study. Total cholesterol, triglycerides, lipoproteins and apolipoproteins. Contraception 1992; 45: 21–37
- Singh K, Viegas O A, Loke D, et al. Effect of Norplant-2 rods on liver, lipid and carbohydrate metabolism. Contraception 1992; 45: 463–72
- Singh K, Viegas O A, Ratnam S S. A three-year evaluation of metabolic changes in Singaporean Norplant-2 rod acceptors. Adv Contracept 1990; 6: 71–80
- Singh K, Viegas O A, Liew D, et al. The effects of Norplant-2 rods on clinical chemistry in Singaporean acceptors after 1 year of use: metabolic changes. Contraception 1988; 38: 453–63
- Kayikcioglu F, Gunes M, Ozdegirmenci O, et al. Effects of levonorgestrel-releasing intrauterine system on glucose and lipid metabolism: A 1-year follow-up study. Contraception 2006; 73: 528–31